1. Home
  2. TRN vs IMNM Comparison

TRN vs IMNM Comparison

Compare TRN & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trinity Industries Inc.

TRN

Trinity Industries Inc.

HOLD

Current Price

$34.09

Market Cap

2.6B

Sector

Industrials

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$18.17

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRN
IMNM
Founded
1933
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Railroads
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.6B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
TRN
IMNM
Price
$34.09
$18.17
Analyst Decision
Hold
Strong Buy
Analyst Count
1
10
Target Price
$34.00
$32.80
AVG Volume (30 Days)
703.7K
1.1M
Earning Date
04-30-2026
05-08-2026
Dividend Yield
4.03%
N/A
EPS Growth
85.98
51.40
EPS
0.30
N/A
Revenue
$2,156,900,000.00
$6,941,000.00
Revenue This Year
$1.91
N/A
Revenue Next Year
$15.61
$1,127.34
P/E Ratio
$113.83
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.38
$7.96
52 Week High
$37.36
$27.65

Technical Indicators

Market Signals
Indicator
TRN
IMNM
Relative Strength Index (RSI) 55.62 32.49
Support Level $31.12 $16.81
Resistance Level $35.33 $19.16
Average True Range (ATR) 1.02 1.16
MACD 0.12 -0.33
Stochastic Oscillator 82.73 0.00

Price Performance

Historical Comparison
TRN
IMNM

About TRN Trinity Industries Inc.

Trinity Industries Inc sells and leases railroad products and railcar maintenance services in North America. The company operates under the name TrinityRail in two main segments: railcar leasing and management services, which owns railcars and provides fleet management and administration services; rail products, which builds, sells, and modifies freight and tank railcars and their components; and all other, which sells highway products such as guardrail and other highway barriers. Customers include railroads, leasing companies, and shipping companies in agriculture, construction, consumer products, energy, and chemicals.

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

Share on Social Networks: